British Society for Gene Therapy Public Open Day
The British Society for Gene Therapy (BSGT) is holding a Public Open Day today at The University of Warwick. As I write this, they should be in the midst of discussing whether gene therapy can be used to treat haemophilia, cystic fibrosis, cancer, and muscular dystrophy. Of particular interest to some of us, science and media will also be discussed along with a workshop on gene therapy in the news. Last year’s program and presentations are also available. More later when this year’s is posted online.
Concurrently, the BSGT Annual Conference starts today and will last until March 21. BBC News reports from the meeting on gene therapy for fetuses.
Dr Simon Waddington of University College London:
There are several advantages. For example, in cystic fibrosis, lung damage is actually occurring before birth.
So, if you can get your gene therapy in before then, you might be able to stop the disease from happening.
If you are going to treat adults it is often too late to reverse some of the damage.
We are not modifying the children’s children, only treating that patient.
Sounds very much in line with Ravgen Chairman and CEO Dr. Rav Dhallan’s goal of beginning disease prevention in the womb.
Tags: gene therapy, womb, fetus, in utero, genetics, genes, genome, dna, diseases, illness, health, medicine, british society for gene therapy
Related Stories
POSTED IN: General Genetics and Health, Genetic Engineering
.gif)
0 opinions for British Society for Gene Therapy Public Open Day
No one has left a comment yet. You know what this means, right? You could be first!
Have an opinion? Leave a comment: